The Relation of Clinical Response and Minimal Residual Disease and Their Prognostic Impact On Outcome in Acute Myeloid Leukemia

被引：2
|
作者：
Chen, Xueyan
Xie, Hu [1 ]
Bohm, Carl
Wood, Brent L. [2 ]
Pagel, John M. [1 ]
Becker, Pamela S. [3 ]
Walter, Roland B. [1 ]
Sandhu, Ravinder K. [1 ]
Abkowitz, Janis L.
Appelbaum, Frederick R. [1 ]
Estey, Elihu H. [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[2] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
[3] Univ Washington, Div Hematol, Seattle, WA 98195 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.1418.1418
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1418
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Assessment of minimal residual disease in acute myeloid leukemia
    Grimwade, David
    Vyas, Paresh
    Freeman, Sylvie
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (06) : 656 - 663
  • [32] Monitoring of minimal residual disease in acute myeloid leukemia
    Buccisano, Francesco
    Maurillo, Luca
    Spagnoli, Alessandra
    Del Principe, Maria Ilaria
    Ceresoli, Eleonora
    Lo Coco, Francesco
    Arcese, William
    Amadori, Sergio
    Venditti, Adriano
    CURRENT OPINION IN ONCOLOGY, 2009, 21 (06) : 582 - 588
  • [33] Complemental Prognostic Impact of Flow Cytometric and Molecular Quantification of Minimal/Measurable Residual Disease in Acute Myeloid Leukemia
    Kern, Wolfgang
    Meggendorfer, Manja
    Haferlach, Claudia
    Haferlach, Torsten
    BLOOD, 2019, 134
  • [34] Prognostic stratification and minimal residual disease assessment in Acute Myeloid Leukemia by molecular techniques
    Kakkas, I.
    ARCHIVES OF HELLENIC MEDICINE, 2013, 30 (05): : 566 - 573
  • [35] Clinical relevance of minimal residual disease detection in adult acute myeloid leukemia
    Venditti, A
    Tamburini, A
    Buccisano, F
    Del Poeta, G
    Maurillo, L
    Panetta, P
    Scornajenghi, KA
    Cox, C
    Amadori, S
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (02): : 349 - 357
  • [36] The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia
    Qin, Ya-Zhen
    Jiang, Qian
    Wang, Yu
    Jiang, Hao
    Xu, Lan-Ping
    Zhao, Xiao-Su
    Zhang, Xiao-Hui
    Liu, Kai-Yan
    Huang, Xiao-Jun
    BLOOD CANCER JOURNAL, 2021, 11 (04)
  • [37] The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia
    Ya-Zhen Qin
    Qian Jiang
    Yu Wang
    Hao Jiang
    Lan-Ping Xu
    Xiao-Su Zhao
    Xiao-Hui Zhang
    Kai-Yan Liu
    Xiao-Jun Huang
    Blood Cancer Journal, 11
  • [38] Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia
    Buccisano, Francesco
    Maurillo, Luca
    Del Principe, Maria Ilaria
    Di Veroli, Ambra
    De Bellis, Eleonora
    Biagi, Annalisa
    Zizzari, Annagiulia
    Rossi, Valentina
    Rapisarda, Vito
    Amadori, Sergio
    Voso, Maria Teresa
    Lo-Coco, Francesco
    Arcese, William
    Venditti, Adriano
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (04) : 307 - 313
  • [39] RESIDUAL HEMATOPOIETIC STEM CELLS REFLECT MINIMAL RESIDUAL DISEASE AND PREDICT OUTCOME IN ACUTE MYELOID LEUKEMIA
    Wang, W.
    Raffel, S.
    Hoang, V.
    Hoffmann, I.
    Saeed, B.
    Miesala, K.
    Trumpp, A.
    Ho, A. D.
    Lutz, C.
    HAEMATOLOGICA, 2015, 100 : 41 - 42
  • [40] IMPACT OF MINIMAL RESIDUAL DISEASE ON OUTCOME OF CHILDREN WITH HYPODIPLOID ACUTE LYMPHOBLASTIC LEUKEMIA
    Sidhom, Iman
    Salem, Sherine
    Ali, Nesreen
    Gohar, Seham
    Shaaban, Khaled
    Soliman, Sonia
    Magdi, Hadeel
    Hammad, Dina
    El-Haddad, Alaa
    PEDIATRIC BLOOD & CANCER, 2018, 65
12345